New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions
Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grade | Version: 0.1.0 | |||
Active as of 2024-11-02 | Computable Name: canshare-grade | |||
Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-grade |
The grade of a cancer
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet canshare-grade
version: 1; Last updated: 2024-11-05 17:15:33+1300; Language: en-x-sctlang-23162100-0210105
http://snomed.info/sct
where constraint = < 384740007 |Finding of grade (finding)| OR < 370114008 |Histological grades (qualifier value)|
Generated Narrative: ValueSet canshare-grade
version: 1; Last updated: 2024-11-05 17:15:33+1300; Language: en-x-sctlang-23162100-0210105
Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024
This value set contains 100 concepts
Code | System | Display - English (English, en) |
369781009 | http://snomed.info/sct | DCIS nuclear pleomorphism, grade 1: monotonous nuclei, 1.5 - 2.0 RBC diameters, with finely dispersed chromatin and only occasional nucleoli |
369782002 | http://snomed.info/sct | DCIS nuclear pleomorphism, grade 2: neither nuclear grade 1 nor nuclear grade 3 |
369783007 | http://snomed.info/sct | DCIS nuclear pleomorphism, grade 3: Markedly pleomorphic nuclei, usually >2.5 RBC diameters, with coarse chromatin and multiple nucleoli |
1290245004 | http://snomed.info/sct | Differentiating neuroblastoma |
1290302009 | http://snomed.info/sct | FIGO (International Federation of Gynecology and Obstetrics) grading system grade 1 |
1290303004 | http://snomed.info/sct | FIGO (International Federation of Gynecology and Obstetrics) grading system grade 2 |
1290304005 | http://snomed.info/sct | FIGO (International Federation of Gynecology and Obstetrics) grading system grade 3 |
396193002 | http://snomed.info/sct | Fuhrman nuclear grade finding |
54102005 | http://snomed.info/sct | G1 grade |
369724004 | http://snomed.info/sct | G1: 5 percent or less non-squamous solid growth |
369720008 | http://snomed.info/sct | G1: Nuclei round, uniform, approximately 10 µ; nucleoli inconspicuous or absent |
1155701009 | http://snomed.info/sct | G1: Well differentiated |
369716009 | http://snomed.info/sct | G1: Well differentiated (greater than 95 percent gland forming) |
1155706004 | http://snomed.info/sct | G1: Well differentiated neuroendocrine neoplasm |
476251000210106 | http://snomed.info/sct | G1: Well differentiated neuroendocrine neoplasm, typical carcinoid of thorax |
1663004 | http://snomed.info/sct | G2 grade |
369725003 | http://snomed.info/sct | G2: 6-50 percent non-squamous solid growth |
1155703007 | http://snomed.info/sct | G2: Moderately differentiated |
369717000 | http://snomed.info/sct | G2: Moderately differentiated (50-95 percent gland forming) |
369721007 | http://snomed.info/sct | G2: Nuclei slightly irregular, approximately 15 µ; nucleoli evident |
1155710001 | http://snomed.info/sct | G2: Well differentiated neuroendocrine neoplasm |
476241000210108 | http://snomed.info/sct | G2: Well differentiated neuroendocrine neoplasm, atypical carcinoid of thorax |
61026006 | http://snomed.info/sct | G3 grade |
369726002 | http://snomed.info/sct | G3: More than 50 percent non-squamous solid growth |
369722000 | http://snomed.info/sct | G3: Nuclei very irregular, approximately 20 µ; nucleoli large and prominent |
1155704001 | http://snomed.info/sct | G3: Poorly differentiated |
369718005 | http://snomed.info/sct | G3: Poorly differentiated (5-49 percent gland forming) |
1155711002 | http://snomed.info/sct | G3: Well differentiated neuroendocrine neoplasm |
258245003 | http://snomed.info/sct | G4 grade |
369723005 | http://snomed.info/sct | G4: Nuclei bizarre and multilobated, 20 µ or greater, nucleoli prominent, chromatin clumped |
1155702002 | http://snomed.info/sct | G4: Undifferentiated |
369719002 | http://snomed.info/sct | G4: Undifferentiated (less than 5 percent gland forming) |
1268929003 | http://snomed.info/sct | GB: Borderline tumour |
384741006 | http://snomed.info/sct | Grade cannot be determined |
477281000210103 | http://snomed.info/sct | Grade determined |
60815008 | http://snomed.info/sct | Grade not determined |
1155705000 | http://snomed.info/sct | GX: Histologic grade cannot be assessed |
1155712009 | http://snomed.info/sct | GX: Neuroendocrine neoplasm grade cannot be assessed |
369767007 | http://snomed.info/sct | High grade (lymphoma) |
395530002 | http://snomed.info/sct | High grade (poorly differentiated to undifferentiated) |
399611001 | http://snomed.info/sct | High grade histologic differentiation |
1155707008 | http://snomed.info/sct | High histologic grade |
476601000210107 | http://snomed.info/sct | High poorly differentiated histologic grade |
373372005 | http://snomed.info/sct | Histological grade finding |
405986005 | http://snomed.info/sct | Intermediate grade histologic differentiation |
1286893008 | http://snomed.info/sct | Intermediate histologic grade |
332391000210102 | http://snomed.info/sct | International Federation of Gynecology and Obstetrics grade 1 |
332401000210104 | http://snomed.info/sct | International Federation of Gynecology and Obstetrics grade 2 |
332411000210102 | http://snomed.info/sct | International Federation of Gynecology and Obstetrics grade 3 |
332381000210104 | http://snomed.info/sct | International Federation of Gynecology and Obstetrics grade finding |
1290294004 | http://snomed.info/sct | International Federation of Gynecology and Obstetrics grading system |
1279715000 | http://snomed.info/sct | International Society of Urological Pathology grade group 1 (Gleason score 3 + 3 = 6) |
1279714001 | http://snomed.info/sct | International Society of Urological Pathology grade group 2 (Gleason score 3 + 4 = 7) |
1279716004 | http://snomed.info/sct | International Society of Urological Pathology grade group 3 (Gleason score 4 + 3 = 7) |
1279718003 | http://snomed.info/sct | International Society of Urological Pathology grade group 4 (Gleason score 3 + 5 = 8) |
1279717008 | http://snomed.info/sct | International Society of Urological Pathology grade group 4 (Gleason score 4 + 4 = 8) |
1279719006 | http://snomed.info/sct | International Society of Urological Pathology grade group 4 (Gleason score 5 + 3 = 8) |
1279720000 | http://snomed.info/sct | International Society of Urological Pathology grade group 5 (Gleason score 4 + 5 = 9) |
1279721001 | http://snomed.info/sct | International Society of Urological Pathology grade group 5 (Gleason score 5 + 4 = 9) |
1279722008 | http://snomed.info/sct | International Society of Urological Pathology grade group 5 (Gleason score 5 + 5 = 10) |
1515521000004104 | http://snomed.info/sct | International Society of Urological Pathology histologic grade group |
1525761000004109 | http://snomed.info/sct | International Society of Urological Pathology histologic grade group 1 |
1525771000004101 | http://snomed.info/sct | International Society of Urological Pathology histologic grade group 2 |
1525781000004103 | http://snomed.info/sct | International Society of Urological Pathology histologic grade group 3 |
1525791000004100 | http://snomed.info/sct | International Society of Urological Pathology histologic grade group 4 |
1525801000004104 | http://snomed.info/sct | International Society of Urological Pathology histologic grade group 5 |
369766003 | http://snomed.info/sct | Low grade (lymphoma) |
395529007 | http://snomed.info/sct | Low grade (well to moderately differentiated) |
399415002 | http://snomed.info/sct | Low grade histologic differentiation |
425037004 | http://snomed.info/sct | Low grade lymphoma, stage 1 |
1155708003 | http://snomed.info/sct | Low histologic grade |
476591000210102 | http://snomed.info/sct | Low well-moderately differentiated histologic grade |
384812005 | http://snomed.info/sct | Moderately differentiated |
373377004 | http://snomed.info/sct | Moderately differentiated histological grade finding |
384668003 | http://snomed.info/sct | Nottingham Combined Grade cannot be determined |
373378009 | http://snomed.info/sct | Nottingham Combined Grade finding |
369790002 | http://snomed.info/sct | Nottingham Combined Grade I: 3-5 points |
369791003 | http://snomed.info/sct | Nottingham Combined Grade II: 6-7 points |
369792005 | http://snomed.info/sct | Nottingham Combined Grade III: 8-9 points |
1287024003 | http://snomed.info/sct | Nottingham combined histologic grade 1 |
1287025002 | http://snomed.info/sct | Nottingham combined histologic grade 2 |
1287026001 | http://snomed.info/sct | Nottingham combined histologic grade 3 |
1287020007 | http://snomed.info/sct | Nottingham grade system for primary malignant neoplasm of breast |
1287460004 | http://snomed.info/sct | Nottingham scoring system for primary malignant neoplasm of breast |
1287021006 | http://snomed.info/sct | Nottingham scoring system for primary malignant neoplasm of breast score 1 |
1287022004 | http://snomed.info/sct | Nottingham scoring system for primary malignant neoplasm of breast score 2 |
1287023009 | http://snomed.info/sct | Nottingham scoring system for primary malignant neoplasm of breast score 3 |
384736003 | http://snomed.info/sct | Nuclear grade finding |
263843001 | http://snomed.info/sct | Poorly differentiated |
373373000 | http://snomed.info/sct | Poorly differentiated histological grade finding |
313147000 | http://snomed.info/sct | Tumour grade G0 |
263918006 | http://snomed.info/sct | Undifferentiated |
373374006 | http://snomed.info/sct | Undifferentiated histological grade finding |
263933003 | http://snomed.info/sct | Well differentiated |
373375007 | http://snomed.info/sct | Well differentiated histological grade finding |
396921005 | http://snomed.info/sct | WHO grade finding for central nervous system tumour |
396922003 | http://snomed.info/sct | WHO grade I (central nervous system tumour) |
396923008 | http://snomed.info/sct | WHO grade II (central nervous system tumour) |
396924002 | http://snomed.info/sct | WHO grade III (central nervous system tumour) |
396925001 | http://snomed.info/sct | WHO grade IV (central nervous system tumour) |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |